Brief: Alx Oncology Announces Evorpacept Clinical Program Updates
03/06/2022 12:23
June 3 (Reuters) - ALX Oncology Holdings Inc ALXO.O :
* ALX ONCOLOGY ANNOUNCES EVORPACEPT CLINICAL PROGRAM UPDATES
* ALX ONCOLOGY HOLDINGS INC - EXPANSION OF SOLID TUMOR
CLINICAL
PROGRAM
* ALX ONCOLOGY HOLDINGS INC - ASPEN-02 DOSE OPTIMIZATION
DATA TO
INFORM DOSING FOR ASPEN-05
Source text for Eikon: ID:nGNX41WFvR
Further company coverage: ALXO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ALX Oncology Holdings
See all newsALX Oncology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
ALX Oncology Holdings Inc expected to post a loss of 15 cents a share - Earnings Preview
ALX Oncology Q2 net loss narrows on lower R&D costs
Brief: ALX Oncology Q2 Basic EPS USD -0.13
Brief: Alx Oncology Holdings - Enters Loan And Security Agreement With HSBC Ventures On June 25, 2026 - SEC Filing